Precigen Inc

NASDAQ:PGEN   3:59:55 PM EDT
4.96
+0.46 (+10.22%)
Products

Precigen Receives FDA Orphan Drug Designation For Prgn-2012 Adenoverse Immunotherapy In Patients With Recurrent Respiratory Papillomatosis

Published: 03/18/2021 13:03 GMT
Precigen Inc (PGEN) - Precigen Receives FDA Orphan Drug Designation for Prgn-2012 Adenoverse™ Immunotherapy in Patients With Recurrent Respiratory Papillomatosis (rrp).